← Leaderboards
Michael T McIntosh
University Of Florida
$1,509,644
Attributed
$3,019,287
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $903.2K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$3,019,287 · 1
By mechanism
U01$3,019,287 · 1
Top collaborators
- Sumita Bhaduri-Mcintosh5 shared
Most similar at University Of Florida
Same institution · by research overlap
- Grant McFadden$8,340,507
- Erik K Flemington$23,678,004
- Rolf F Renne$15,821,379
- Xingming Deng$11,809,682
- Stanley Barrett Pounds$2,845,206
Others in their field
Other Rising Stars on “S Lymphoma”
- David G Brooks · Boston Immune Technologies And Therapeutics, Inc.$3,974,764
- Arthur P Bertolino · Cytoagents, Inc.$3,313,557
- Saad J. Kenderian · Mayo Clinic Rochester$2,679,817
- Erin Marcotte · University Of Minnesota$2,501,446
- Nadine Norton · Mayo Clinic Jacksonville$2,431,858
- Caroline Uhler · Broad Institute, Inc.$2,298,000
Research focus
S LymphomaNon-Hodgkin&AposHuman Herpesvirus 4PolymeraseTherapeutic TargetCancer CellMalignant NeoplasmsLarge Cell Diffuse Non-Hodgkin&AposNovel Therapeutic InterventionPersonsResponseTargeted AgentPredispositionPathway InteractionsDna RepairHomologous RecombinationImproved OutcomeInhibitorMediatingCancer Specimen ResourceCancer EtiologyDna-Directed Dna PolymeraseAnti-Retroviral AgentsClinical Risk
Grant awards (5)
Synthetic lethal targeting of EBV-positive diffuse large B cell lymphomas in persons living with HIV$676,145
U01 · FY2025 · CA
Synthetic lethal targeting of EBV-positive diffuse large B cell lymphomas in persons living with HIV$750,686
U01 · FY2024 · CA
PROTAC-based direct and oncolytic killing of EBV+ DLBCLs through synthetic lethality$152,500
U01 · FY2024 · CA
Synthetic lethal targeting of EBV-positive diffuse large B cell lymphomas in persons living with HIV$750,686
U01 · FY2023 · CA
Synthetic lethal targeting of EBV-positive diffuse large B cell lymphomas in persons living with HIV$689,270
U01 · FY2022 · CA